Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Pneumococcal vaccination in adults: does it really work?

Pitsiou GG, Kioumis IP.

Respir Med. 2011 Dec;105(12):1776-83. doi: 10.1016/j.rmed.2011.07.008. Epub 2011 Aug 4. Review.

2.

Advances in pneumococcal vaccines: what are the advantages for the elderly?

Vila-Córcoles A.

Drugs Aging. 2007;24(10):791-800. Review.

PMID:
17896829
3.

Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.

Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, Salleras L, Samson SI.

Expert Rev Vaccines. 2011 Aug;10(8):1143-67. doi: 10.1586/erv.11.99. Epub 2011 Aug 3. Review.

PMID:
21810065
4.

Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.

Zangeneh TT, Baracco G, Al-Tawfiq JA.

Expert Rev Vaccines. 2011 Mar;10(3):345-53. doi: 10.1586/erv.11.1. Review.

PMID:
21434802
5.
6.

Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults.

Gaillat J.

Med Mal Infect. 2013 Jun;43(6):215-21. doi: 10.1016/j.medmal.2013.04.005. Epub 2013 Jun 13. Review.

PMID:
23769155
7.

Pneumococcal vaccines.

Ho CF, Lin TY.

Chang Gung Med J. 2005 Nov;28(11):765-72. Review.

8.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
9.

Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine.

Whitney CG, Klugman KP.

Semin Pediatr Infect Dis. 2004 Apr;15(2):86-93. Review.

PMID:
15185191
10.

Pneumococcal disease in the elderly: what is preventing vaccine efficacy?

Rubins JB, Janoff EN.

Drugs Aging. 2001;18(5):305-11. Review.

PMID:
11392439
11.
12.

Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Croxtall JD, Keating GM.

Paediatr Drugs. 2009;11(5):349-57. doi: 10.2165/11202760-000000000-00000. Review.

PMID:
19725600
13.

Pneumococcal conjugate vaccine.

Ledwith M.

Curr Opin Pediatr. 2001 Feb;13(1):70-4. Review.

PMID:
11176248
14.

Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.

Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM.

Pharmacoeconomics. 2011 Mar;29(3):199-211. doi: 10.2165/11584930-000000000-00000. Review.

PMID:
21250759
15.

The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.

Giglio N, Micone P, Gentile A.

Vaccine. 2011 Sep 14;29 Suppl 3:C35-42. doi: 10.1016/j.vaccine.2011.06.095. Review.

PMID:
21896351
16.

Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.

Vila-Corcoles A, Ochoa-Gondar O.

Expert Rev Vaccines. 2012 Feb;11(2):221-36. doi: 10.1586/erv.11.176. Review.

PMID:
22309670
17.

The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.

Toltzis P, Jacobs MR.

Infect Dis Clin North Am. 2005 Sep;19(3):629-45. Review.

PMID:
16102653
18.

Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions.

Ogilvie I, Khoury AE, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M.

Vaccine. 2009 Aug 6;27(36):4891-904. doi: 10.1016/j.vaccine.2009.05.061. Epub 2009 Jun 9. Review.

PMID:
19520205
20.

Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?

Jakobsen H, Jonsdottir I.

Scand J Immunol. 2003 Aug;58(2):119-28. Review.

Supplemental Content

Support Center